These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29774305)

  • 1. Multi-slice MRI reveals heterogeneity in disease distribution along the length of muscle in Duchenne muscular dystrophy.
    Chrzanowski SM; Baligand C; Willcocks RJ; Deol J; Schmalfuss I; Lott DJ; Daniels MJ; Senesac C; Walter GA; Vandenborne K
    Acta Myol; 2017 Sep; 36(3):151-162. PubMed ID: 29774305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower leg muscle involvement in Duchenne muscular dystrophy: an MR imaging and spectroscopy study.
    Torriani M; Townsend E; Thomas BJ; Bredella MA; Ghomi RH; Tseng BS
    Skeletal Radiol; 2012 Apr; 41(4):437-45. PubMed ID: 21800026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic Resonance Assessment of Hypertrophic and Pseudo-Hypertrophic Changes in Lower Leg Muscles of Boys with Duchenne Muscular Dystrophy and Their Relationship to Functional Measurements.
    Vohra RS; Lott D; Mathur S; Senesac C; Deol J; Germain S; Bendixen R; Forbes SC; Sweeney HL; Walter GA; Vandenborne K
    PLoS One; 2015; 10(6):e0128915. PubMed ID: 26103164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utilisation of multimodal quantitative magnetic resonance imaging in investigating muscular damage in Duchenne muscular dystrophy: a study on the association between gluteal muscle groups and motor function.
    Song Y; Xu HY; Xu K; Guo YK; Xie LJ; Peng F; Xu R; Fu H; Yuan WF; Zhou ZQ; Cheng BC; Fu C; Zhou H; Cai XT; Li XS
    Pediatr Radiol; 2023 Jul; 53(8):1648-1658. PubMed ID: 36892624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal muscle water T
    Mankodi A; Azzabou N; Bulea T; Reyngoudt H; Shimellis H; Ren Y; Kim E; Fischbeck KH; Carlier PG
    Neuromuscul Disord; 2017 Aug; 27(8):705-714. PubMed ID: 28601553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upper Limb Evaluation in Duchenne Muscular Dystrophy: Fat-Water Quantification by MRI, Muscle Force and Function Define Endpoints for Clinical Trials.
    Ricotti V; Evans MR; Sinclair CD; Butler JW; Ridout DA; Hogrel JY; Emira A; Morrow JM; Reilly MM; Hanna MG; Janiczek RL; Matthews PM; Yousry TA; Muntoni F; Thornton JS
    PLoS One; 2016; 11(9):e0162542. PubMed ID: 27649492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upper and Lower Extremities in Duchenne Muscular Dystrophy Evaluated with Quantitative MRI and Proton MR Spectroscopy in a Multicenter Cohort.
    Forbes SC; Arora H; Willcocks RJ; Triplett WT; Rooney WD; Barnard AM; Alabasi U; Wang DJ; Lott DJ; Senesac CR; Harrington AT; Finanger EL; Tennekoon GI; Brandsema J; Daniels MJ; Sweeney HL; Walter GA; Vandenborne K
    Radiology; 2020 Jun; 295(3):616-625. PubMed ID: 32286193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging and spectroscopy assessment of lower extremity skeletal muscles in boys with Duchenne muscular dystrophy: a multicenter cross sectional study.
    Forbes SC; Willcocks RJ; Triplett WT; Rooney WD; Lott DJ; Wang DJ; Pollaro J; Senesac CR; Daniels MJ; Finkel RS; Russman BS; Byrne BJ; Finanger EL; Tennekoon GI; Walter GA; Sweeney HL; Vandenborne K
    PLoS One; 2014; 9(9):e106435. PubMed ID: 25203313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-uniform muscle fat replacement along the proximodistal axis in Duchenne muscular dystrophy.
    Hooijmans MT; Niks EH; Burakiewicz J; Anastasopoulos C; van den Berg SI; van Zwet E; Webb AG; Verschuuren JJGM; Kan HE
    Neuromuscul Disord; 2017 May; 27(5):458-464. PubMed ID: 28302391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T2 Mapping and Fat Quantification of Thigh Muscles in Children with Duchenne Muscular Dystrophy.
    Yin L; Xie ZY; Xu HY; Zheng SS; Wang ZX; Xiao JX; Yuan Y
    Curr Med Sci; 2019 Feb; 39(1):138-145. PubMed ID: 30868504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying disease activity in fatty-infiltrated skeletal muscle by IDEAL-CPMG in Duchenne muscular dystrophy.
    Mankodi A; Bishop CA; Auh S; Newbould RD; Fischbeck KH; Janiczek RL
    Neuromuscul Disord; 2016 Oct; 26(10):650-658. PubMed ID: 27593185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle histology vs MRI in Duchenne muscular dystrophy.
    Kinali M; Arechavala-Gomeza V; Cirak S; Glover A; Guglieri M; Feng L; Hollingsworth KG; Hunt D; Jungbluth H; Roper HP; Quinlivan RM; Gosalakkal JA; Jayawant S; Nadeau A; Hughes-Carre L; Manzur AY; Mercuri E; Morgan JE; Straub V; Bushby K; Sewry C; Rutherford M; Muntoni F
    Neurology; 2011 Jan; 76(4):346-53. PubMed ID: 21263136
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Gerhalter T; Gast LV; Marty B; Martin J; Trollmann R; Schüssler S; Roemer F; Laun FB; Uder M; Schröder R; Carlier PG; Nagel AM
    J Magn Reson Imaging; 2019 Oct; 50(4):1103-1113. PubMed ID: 30719784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postcontractile blood oxygenation level-dependent (BOLD) response in Duchenne muscular dystrophy.
    Lopez C; Taivassalo T; Berru MG; Saavedra A; Rasmussen HC; Batra A; Arora H; Roetzheim AM; Walter GA; Vandenborne K; Forbes SC
    J Appl Physiol (1985); 2021 Jul; 131(1):83-94. PubMed ID: 34013753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T₂ mapping provides multiple approaches for the characterization of muscle involvement in neuromuscular diseases: a cross-sectional study of lower leg muscles in 5-15-year-old boys with Duchenne muscular dystrophy.
    Arpan I; Forbes SC; Lott DJ; Senesac CR; Daniels MJ; Triplett WT; Deol JK; Sweeney HL; Walter GA; Vandenborne K
    NMR Biomed; 2013 Mar; 26(3):320-8. PubMed ID: 23044995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle MRI in Duchenne muscular dystrophy: Evidence of a distinctive pattern.
    Polavarapu K; Manjunath M; Preethish-Kumar V; Sekar D; Vengalil S; Thomas P; Sathyaprabha TN; Bharath RD; Nalini A
    Neuromuscul Disord; 2016 Nov; 26(11):768-774. PubMed ID: 27666775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of intramuscular lipid and metabolites of the lower leg using magnetic resonance spectroscopy in boys with Duchenne muscular dystrophy.
    Lott DJ; Forbes SC; Mathur S; Germain SA; Senesac CR; Lee Sweeney H; Walter GA; Vandenborne K
    Neuromuscul Disord; 2014 Jul; 24(7):574-82. PubMed ID: 24798221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal Evaluation of Muscle Composition Using Magnetic Resonance in 4 Boys With Duchenne Muscular Dystrophy: Case Series.
    Senesac CR; Lott DJ; Forbes SC; Mathur S; Arpan I; Senesac ES; Walter GA; Vandenborne K
    Phys Ther; 2015 Jul; 95(7):978-88. PubMed ID: 25592189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related differences in lower-limb muscle cross-sectional area and torque production in boys with Duchenne muscular dystrophy.
    Mathur S; Lott DJ; Senesac C; Germain SA; Vohra RS; Sweeney HL; Walter GA; Vandenborne K
    Arch Phys Med Rehabil; 2010 Jul; 91(7):1051-8. PubMed ID: 20599043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal measurements of MRI-T2 in boys with Duchenne muscular dystrophy: effects of age and disease progression.
    Willcocks RJ; Arpan IA; Forbes SC; Lott DJ; Senesac CR; Senesac E; Deol J; Triplett WT; Baligand C; Daniels MJ; Sweeney HL; Walter GA; Vandenborne K
    Neuromuscul Disord; 2014 May; 24(5):393-401. PubMed ID: 24491484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.